While the study by Swaminathan et al. explores the effect of copy number variation (CNV) derived by genome-wide screening in the ADNI cohort on AD and MCI, the study by Tedde et al. explores the effect of genetic variation in CDKN2A and CDKN2B on AD. Here, CDKN2A is linked to Alzheimer disease.